Advertisement

Topics

Companies Related to "Tempus Announces Latest Immunotherapy Project" [Most Relevant Company Matches] RSS

00:22 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Tempus Announces Latest Immunotherapy Project" found in our extensive corporate database of over 50,000 company records.

Showing "Tempus Announces Latest Immunotherapy Project" Companies 1–25 of 1,600+

Extremely Relevant

Tempus

Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and an...


Relevant

Immunomic Therapeutics, Inc. and ZENOAQ

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. ITI has entered into a significant licensing agreement with ...

The Meth Project

The Meth Project is a national non-profit organization headquartered in Palo Alto, California, aimed at significantly reducing Meth use through public service messaging, public policy, and community outreach. Central to its integrated campaign is MethProject.org—a definitive source for information about Meth for teens. The Montana Meth Project, Arizona Meth ...


NextCure, Inc.

NextCure is a biopharmaceutical company focused on discovering and developing next generation first-in-class immunotherapy-based biologics for cancer and other diseases. The company leverages its FIND-IOTM technology to discover, validate and build a proprietary pipeline of novel immunotherapy targets.

United Allergy Services

United Allergy Services™ (UAS) brings effective and convenient allergy testing and immunotherapy to primary care physicians; pulmonologists; ENT physicians; pediatricians; internal medicine physicians; and healthcare systems that treat the vast majority of patients with seasonal and perennial allergies. UAS’ complete service line features ...

OncoImmunity

OncoImmunity is a machine-learning company offering a proprietary technology to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity's software facilitates effective patient selection for cancer immunotherapy, and identifies optimal neoantigen targets for truly personal...

TNI BioTech, Inc.

TNI BioTech, Inc. is a biotech company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using our patented immunotherapy. Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, ch...

CARMA Therapeutics Inc.

CARMA TherapeuticsSM is a biotechnology company founded in 2016 to bring the power of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA). The company’s proprietary technology was developed at the Center for Cellular Immunotherapy at the Perelman School of Medicine at the...

Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles...

Resistentia Pharmaceuticals AB

Resistentia Pharmaceuticals AB is a biotechnology company focusing on the development of innovative immunotherapies. The Company’s lead project is an immunotherapy for the treatment of allergy/asthma. Building on over 10 years of academic research, Resistentia was founded in 1998. Since then, the Company has developed an industrial organization consisting of close to 20 people, comprising manage...

Allergy Immuno Technologies Incorporated

Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a clinical reference laboratory at 1527 Monrovia Avenue, Newport Beach, CA, for allergy and other diagnostic testing services for physicians, other laboratories and pharmaceutical companies. As a resul...

INSITE Consultancy Inc.

We use formal project methodologies and develop the project structure to suit the needs and complexity of the project. Together with our experience in the healthcare sector your project will be planned and delivered to produce the best possible outcome.The application of project management techniques to clearly defined objectives is often critical to a successful outcome. Our methods are tailore...

NeoImmuneTech, Inc.

NeoImmuneTech (NIT), a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, Hyleukin-7, in the U.S. and EU. Based in Rockville, Maryland, NIT has the core competency of global clinical and business development with a strong scientific focus and a broad network of global leading R&D ...

NeoImmuneTech

NeoImmuneTech, a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, HyLeukin-7, in the US and EU. Based in Rockville, Maryland, NeoImmuneTech has the core competency of global clinical and business development with a strong scientific focus and a broad network of global leading R&...

Accelerated Cure Project

Accelerated Cure Project for Multiple Sclerosis, www.acceleratedcure.org, is a national nonprofit organization dedicated to curing Multiple Sclerosis (MS) by determining its causes. Accelerated Cure Project believes this effort can be accelerated by organizing the research process and encouraging collaboration between research organizations and clinicians....

Bio Research Laboratories, Inc

At BRL, we believe that superior service is key to our success. During each test, an experienced project manager works with you from the initial consulting stage to the final report and follow-up. Your project manager keeps you up-to-date on test status, scheduling, reporting, and billing, and is available for any questions you may have during the course of your project.

Paratek Pharmaceuticals Incorporated

Paratek's mission is to overcome the major worldwide problem of bacterial resistance through the application of new proprietary technology and through the development of new antibiotics. Paratek has established two product development programs to identify and develop new pharmaceuticals for the treatment of infectious diseases:The Tetracycline Resistance Project ("Tet Project") based on expertise ...

Quantum Medical Communications

Quantum is a global, industry-leading provider of regulatory and pharmacovigilance writing, project management and consultancy. Its specialization ensures high-quality, accurate, and concise documents that conform to the latest international and/or national regulations and guidelines. Our efficient project management ensures we meet your needs on time, to specification and on budget.Quantum sets ...

Immunomic Therapeutics, Inc.(ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. On the heels of two landmark deals in 2015, including an exc...

Immunomic Therapeutics (ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. On the heels of two landmark deals in 2015, including an ...

Probably Relevant

International HapMap Project

The International HapMap Project is a multi-country effort to identify and catalog genetic similarities and differences in human beings. Using the information in the HapMap, researchers will be able to find genes that affect health, disease, and individual responses to medications and environmental factors. The Project is a collaboration among scientists and funding agencies from Japan, the United...

Project Wildlife

The mission of Project Wildlife is to improve the quality of life for local wildlife and the community as the primary resource for wildlife rehabilitation and education. Established in 1972, Project Wildlife works with purpose and passion on behalf of wild animals in Southern California, encouraging sustainable solutions through resolution of wildlife conf...

HST Global, Inc.

HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the immunotherapy and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In thi...

Rigrodsky & Long, P.A.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of BioClinica, Inc. (“BioClinica” or the “Company”) (NASDAQ GM: BIOC) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by J...

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a privately held biopharmaceutical company focused on applying a novel, small molecule immunotherapy platform to treat severe fungal infections in immune-compromised patients. Cidara recently announced that it has completed a $32 million Series A financing that will enable it to advance candidates from the company’s Cloudb...


More From BioPortfolio on "Tempus Announces Latest Immunotherapy Project"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks